SCHEDULE: Nantahala Capital Boosts DarioHealth Stake to 9.99%

Nantahala Capital Management and its managing members disclosed a 9.99% beneficial ownership stake in DarioHealth Corp., including shares from exercisable warrants.

Summary

• Nantahala Capital Management, LLC, along with Wilmot B. Harkey and Daniel Mack, reported beneficial ownership of 4,690,019 shares of DarioHealth Corp. Common Stock.
• This aggregate amount represents 9.99% of DarioHealth Corp.'s outstanding common stock as of June 30, 2025.
• The reported shares include 2,997,716 shares that can be acquired by the Reporting Persons within sixty days through the exercise of warrants.
• Nantahala Capital Management, LLC is classified as an investment adviser, while Wilmot B. Harkey and Daniel Mack are classified as control persons.
• The shares are held by funds and separately managed accounts under Nantahala's control, with shared voting and dispositive power over the entire stake.
• Two specific funds advised by Nantahala, NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP and BLACKWELL PARTNERS LLC SERIES A, each hold more than five percent of the outstanding common stock beneficially owned by Nantahala.

Sentiment

Score: 5

Explanation: The filing is a neutral, factual disclosure of beneficial ownership and does not contain information that would significantly sway sentiment positively or negatively beyond the confirmation of a significant institutional stake.

Positives

• A significant institutional investor, Nantahala Capital Management, maintains a substantial stake, indicating continued confidence in DarioHealth Corp.

Negatives

• NA

Risks

• The filing itself does not detail specific company risks beyond the ownership structure. It certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Future Outlook

This Schedule 13G filing is a disclosure of beneficial ownership and does not contain forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Industry Context

This filing is a routine disclosure of beneficial ownership by an institutional investor in a publicly traded company. It does not provide specific insights into broader industry trends or competitive landscape, but it indicates continued investment interest in the digital health sector, where DarioHealth operates.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake by Nantahala Capital Management may be viewed positively, indicating investor confidence. The potential exercise of warrants could lead to share dilution if new shares are issued, or a change in ownership structure if existing shares are acquired.

Key Dates

Keywords

DarioHealth Corp, Nantahala Capital Management, Beneficial Ownership, SEC Filing, Common Stock, Investment Adviser, Warrants, Healthcare Technology, Digital Health